|
CN112210008A
|
|
Novel anti-human MSLN antibody and application thereof
|
|
CN111560072A
|
|
Anti-human MSLN antibodies and MSLN-targeted immune effector cells
|
|
CN112225811A
|
|
Novel anti-human MSLN antibodies and uses thereof
|
|
CN111349606A
|
|
Use of P60 inhibitors in combination with cart cells
|
|
CN111351935A
|
|
BCMA-CAR affinity detection method
|
|
CN111349173A
|
|
Methods and uses for targeting CCR4 chimeric antigen receptors
|
|
CN111349605A
|
|
Preparation of CAR-T cells co-expressing Treg inhibitor P60
|
|
CN111349174A
|
|
Targeting GPC3 chimeric antigen receptors
|
|
CN111351936A
|
|
CD19-CAR affinity detection method
|
|
CN111218465A
|
|
Chimeric antigen receptor method targeting CD22 and application
|
|
CN111198150A
|
|
CART cell release detection method for infusion
|
|
CN111198199A
|
|
CART cell cryopreservation liquid detection method
|
|
CN111197060A
|
|
Research method for targeted therapy of hematologic malignancy
|
|
CN111100207A
|
|
Preparation method of mixed CD19 and CD22 target point CART cell
|
|
CN111100205A
|
|
Chimeric antigen receptor method targeting novel GPC3 and CD19 double targets
|
|
CN111100206A
|
|
Chimeric antigen receptor method targeting mesothelin and CD19 double targets
|
|
CN111100952A
|
|
Method for detecting CAR virus-related titer
|
|
CN110938641A
|
|
Chimeric antigen receptor targeting APRIL and uses thereof
|
|
CN110935034A
|
|
Detection method for evaluating immunogenicity of CART cells after infusion
|
|
CN109320615A
|
|
Target the Chimeric antigen receptor and application thereof of novel B CMA
|
